Area of research
Cardiology and Cardiovascular Medicine · Genetics
Research interest
Research interests include Heart Failure Treatment and Management, Cardiovascular Function and Risk Factors, Genetic Associations and Epidemiology, and Folate and B Vitamins Research.
Common-variant and rare-variant genetic architecture of heart failure across the allele-frequency spectrum
Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fraction
Diversity and scale: Genetic architecture of 2068 traits in the VA Million Veteran Program
Evolution and prognosis of tricuspid and mitral regurgitation following cardiac implantable electronic devices: a systematic review and meta-analysis
Sex-stratified genome-wide association and transcriptome-wide Mendelian randomization studies reveal drug targets of heart failure
Atrial fibrillation and risk of adverse outcomes in heart failure with reduced, mildly reduced, and preserved ejection fraction: A systematic review and meta‐analysis
Spironolactone Reduces the Risk of Death in Veterans With Heart Failure With Preserved Ejection Fraction
Catheter ablation for atrial fibrillation in patients with significant mitral regurgitation: A systematic review and meta-analysis
Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failure
Pragmatic evaluation of events and benefits of lipid lowering in older adults ( <scp>PREVENTABLE</scp> ): Trial design and rationale
Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk
Genome-wide association and multi-trait analyses characterize the common genetic architecture of heart failure
<i>APOL1</i> Risk Variants, Acute Kidney Injury, and Death in Participants With African Ancestry Hospitalized With COVID-19 From the Million Veteran Program
Genetic architecture of heart failure with preserved versus reduced ejection fraction
Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses
A <i>MUC5B</i> Gene Polymorphism, rs35705950-T, Confers Protective Effects Against COVID-19 Hospitalization but Not Severe Disease or Mortality
Association of Kidney Comorbidities and Acute Kidney Failure With Unfavorable Outcomes After COVID-19 in Individuals With the Sickle Cell Trait
Genetic Loci Associated With COVID-19 Positivity and Hospitalization in White, Black, and Hispanic Veterans of the VA Million Veteran Program
Are Arrhythmias the Drivers of Sudden Cardiac Death in Heart Failure with Preserved Ejection Fraction? A Review
Association of Post-Vaccination Adverse Reactions After Influenza Vaccine with Mortality and Cardiopulmonary Outcomes in Patients with High-Risk Cardiovascular Disease: The INVESTED Trial
Trends in Ischemic Evaluation in New-Onset Heart Failure Without Known Coronary Artery Disease
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19
Risk Factors and Prediction Models for Incident Heart Failure with Reduced and Preserved Ejection Fraction
Association of pulse rate with outcomes in heart failure with reduced ejection fraction: a retrospective cohort study
Risk of ventricular arrhythmia in cardiac resynchronization therapy responders and super-responders: a systematic review and meta-analysis
Development and validation of a heart failure with preserved ejection fraction cohort using electronic medical records
Prognostic Significance of Baseline Serum Sodium in Heart Failure With Preserved Ejection Fraction
Impact of patient-centred home telehealth programme on outcomes in heart failure
Comparison of Outcomes in Patients With Diabetes Mellitus Treated With Versus Without Insulin + Heart Failure With Preserved Left Ventricular Ejection Fraction (from the TOPCAT Study)
Analysis of Skeletal Muscle Gene Expression Patterns and the Impact of Functional Capacity in Patients With Systolic Heart Failure